Tandem Diabetes Care, Inc.
NASDAQ:TNDMMedical - Devices
+$0.24 today
- Market cap
- $1.17B
- Beta
- 1.57
- P/E (TTM)
- -11.3
- EPS (TTM)
- -$1.38
Volume 2.30M
Average 2.43M
Returns on capital
Tandem Diabetes Care, Inc. management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
ROE
-131.9%
avg 106.5%
ROIC
-11.9%
avg -34.1%
ROA
-23.2%
avg -31.3%
Analysis
ROIC is currently the strongest return metric at -11.9% versus its period average of -34.1%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
John F. Sheridan | President, Chief Executive Officer & Director | USD 1.49M | 71 | 17.95K | 0.03% |
Leigh A. Vosseller | Executive Vice President, Chief Financial Officer & Treasurer | USD 764.04K | 53 | — | — |
Elizabeth Anne Gasser | Executive Vice President and Chief Strategy & Product Officer | USD 712.21K | 50 | 508 | <0.01% |
Shannon Hansen | Executive Vice President, Chief Legal, Privacy & Compliance Officer and Secretary | USD 712.17K | 60 | — | — |
Susan Morrison | Executive Vice President & Chief Administrative Officer | USD 697.84K | 47 | 3.29K | <0.01% |
Jean-Claude E. Kyrillos | Executive Vice President & Chief Operating Officer | USD 538.56K | 62 | — | — |
Jordan Pinsker | Chief Medical Officer | — | — | — | — |
Tom Fox | Executive VP & Chief Human Resources Officer | — | — | — | — |
Rick A. Carpenter | Executive VP & CTO | — | 63 | — | — |
Compensation is shown in the reported currency; data updated Nov 7, 2026.
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Aug 15, 2026.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
0
$0.00
Sells
3
$36,910.97
Net Transaction Value
−$36,910.97
Net selling
Most Active
Novara Mark David
2 transactions
Transactions sorted by date, descending.
| Type | |||
|---|---|---|---|
| Oct 27, 26Oct 27, 2026 | TWOMEY CHRISTOPHER J Direct | Sell | $32.6K$32,555.00 |
| Mar 17, 26Mar 17, 2026 | Novara Mark David Direct | Sell | $4.3K$4,310.35 |
| Mar 5, 26Mar 5, 2026 | Novara Mark David Direct | Sell | $45.6$45.62 |
Summary
Insiders reported 0 buys worth $0.00 and 3 sells worth $36,910.97 over the last 12 months. That adds up to net selling of $36,910.97. Novara Mark David was the most active insider with 2 transactions.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A13 analysts |
| Revenue | N/A | N/A | +8.2% | +10.1% (5yr)9 analysts |
| Net Income | N/A | N/A | N/A | N/A9 analysts |
| EBIT | N/A | N/A | N/A | N/A9 analysts |
Analysis
Recent growth has been strongest in Revenue at +8.2% over three years. Forward estimates point to Revenue at +10.1% (5yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Who does Tandem Diabetes Care, Inc. compete with?
Open similar companies to compare how their management teams allocate capital.
Questions
Management questions
Common questions about TNDM's management, answered from reported figures.
Who manages TNDM?
Tandem Diabetes Care, Inc. (TNDM) lists 9 active executives. The top listed executive is Jordan Pinsker, Chief Medical Officer.
Are TNDM insiders buying or selling?
Recent insider activity shows net selling of $1.45M.
Continue the stock analysis
Jump to another research area for this company.